Dietary Supplements

State and local policy issues impacting dietary supplements across the country.

Last week, CHPA, the American Herbal Products Association, the Council for Responsible Nutrition, and the United Natural Products Alliance sent a letter to Senators Tammy Baldwin (D-Wisc.) and John Hoeven (R-N.D.), the Chair and Ranking Member of the Appropriations Subcommittee that has jurisdiction over FDA funding, highlighting the need for additional resources for the Office of Dietary Supplement Programs at FDA due to the growing dietary supplement market.

Last week, Senators Chris Coons (D-Del.) and Thom Tillis (R-N.C.) introduced the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act, intended to protect consumers by stopping the online sale of harmful counterfeit products. This follows introduction of the same legislation by House Judiciary Committee Chairman Jerrold Nadler (D-N.Y.) and Congressmen Darrell Issa (R-Calif.), Henry C. "Hank" Johnson, Jr. (D-Ga.), and Ben Cline (R-Va.).

State and local policy issues impacting dietary supplements across the country.

A summary of selected literature articles related to dietary supplements from the NIH PubMed database that might be of interest to CHPA member companies.

On Tuesday, CHPA President & CEO Scott Melville spoke at an event on Capitol Hill about H.R. 841, legislation that would provide a pathway for dietary supplements containing CBD to be legally marketed.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details. 

This week, CHPA submitted written testimony in opposition New York Assembly Bill 431-B, which prohibits individuals under the age of 18 from buying dietary supplements and OTC drugs for weight loss.

State and local policy issues impacting dietary supplements across the country.